Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1861 AL 1875

Biochemical premotor biomarkers for Parkinson's disease

Mollenhauer B, Zhang J.

Mov Disord. 2012 Apr 15;27(5):644-50. doi: 10.1002/mds.24956.

Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective

Streffer JR, Grachev ID, Fitzer-Attas C, Gomez-Mancilla B, Boroojerdi B, Bronzova J, Ostrowitzki S, Victor SJ, Fontoura P, Alexander R.

Mov Disord. 2012 Apr 15;27(5):651-5. doi: 10.1002/mds.25017.

Defining at-risk populations for Parkinson's disease: lessons from ongoing studies

Berg D, Marek K, Ross GW, Poewe W.

Mov Disord. 2012 Apr 15;27(5):656-65. doi: 10.1002/mds.24985.

The significance of defining preclinical or prodromal Parkinson's disease

Olanow CW, Obeso JA.

Mov Disord. 2012 Apr 15;27(5):666-9. doi: 10.1002/mds.25019.

Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease

Brod LS, Aldred JL, Nutt JG.

Mov Disord. 2012 May;27(6):750-3. doi: 10.1002/mds.24998. Epub 2012 Apr 16.

Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease

Shiner T, Seymour B, Wunderlich K, Hill C, Bhatia KP, Dayan P, Dolan RJ.

Brain. 2012 Jun;135(Pt 6):1871-83. doi: 10.1093/brain/aws083. Epub 2012 Apr 15.

Upper limb tremor

Kimber TE, Thompson PD.

Med J Aust. 2012 Apr 16;196(7):447-51. doi: 10.5694/mja11.11565.

The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients

Maremmani C, Rossi G, Tambasco N, Fattori B, Pieroni A, Ramat S, Napolitano A, Vanni P, Serra P, Piersanti P, Zanetti M, Coltelli M, Orsini M, Marconi R, Purcaro C, Rossi A, Calabresi P, Meco G.

Parkinsonism Relat Disord. 2012 Jul;18(6):788-93. doi: 10.1016/j.parkreldis.2012.03.021. Epub 2012 Apr 15.

Melatonin synthetic analogs as nitric oxide synthase inhibitors

Camacho ME, Carrion MD, Lopez-Cara LC, Entrena A, Gallo MA, Espinosa A, Escames G, Acuna-Castroviejo D.

Mini Rev Med Chem. 2012 Jun;12(7):600-17. doi: 10.2174/138955712800626674.

Construction and validation of the Dynamic Parkinson Gait Scale (DYPAGS)

Crémers J, Phan Ba R, Delvaux V, Garraux G.

Parkinsonism Relat Disord. 2012 Jul;18(6):759-64. doi: 10.1016/j.parkreldis.2012.03.012. Epub 2012 Apr 17.

Trunk-arm coordination in reaching for moving targets in people with Parkinson's disease: comparison between virtual and physical reality

Ma HI, Hwang WJ, Wang CY, Fang JJ, Leong IF, Wang TY.

Hum Mov Sci. 2012 Oct;31(5):1340-52. doi: 10.1016/j.humov.2011.11.004. Epub 2012 Apr 17.

Aceruloplasminemia

Kono S.

Curr Drug Targets. 2012 Aug;13(9):1190-9. doi: 10.2174/138945012802002320.

Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1

Lin J, Prahlad J, Wilson MA.

Biochemistry. 2012 May 8;51(18):3799-807. doi: 10.1021/bi3003296. Epub 2012 Apr 24.

Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation

Fasano A, Daniele A, Albanese A.

Lancet Neurol. 2012 May;11(5):429-42. doi: 10.1016/S1474-4422(12)70049-2.

Structural comparison of mouse and human α-synuclein amyloid fibrils by solid-state NMR

Lv G, Kumar A, Giller K, Orcellet ML, Riedel D, Fernández CO, Becker S, Lange A.

J Mol Biol. 2012 Jun 29;420(1-2):99-111. doi: 10.1016/j.jmb.2012.04.009. Epub 2012 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias